HC Biologics is pleased to announce its participation in Medical Fair Asia 2026, one of the leading healthcare exhibitions in the Asia-Pacific region. The event will take place from September 9–11, 2026, at Marina Bay Sands in Singapore, bringing together healthcare professionals, manufacturers, distributors, and industry leaders from around the world.
During the exhibition, HC Biologics will showcase a selection of innovative solutions across biologics, orthopedics, spine, neurosurgery, and advanced surgical technologies. Visitors will have the opportunity to explore our expanding portfolio and learn how our products are designed to support evolving clinical needs and modern surgical procedures.
Our participation in Medical Fair Asia 2026 reflects HC Biologics’ continued commitment to strengthening its presence throughout the Asia-Pacific region and developing long-term relationships with healthcare professionals and distribution partners. The event will provide an important platform for exchanging industry knowledge, identifying new opportunities, and discussing the needs of different international markets.
We invite attendees to visit HC Biologics at Booth 2G09 to meet our team, discover our product portfolio, and discuss potential distribution, strategic partnership, and business development opportunities across the region.
We look forward to connecting with healthcare professionals and industry partners in Singapore and sharing the technologies and solutions that continue to drive the international growth of HC Biologics.
HC Biologics is pleased to participate in EUROSPINE 2026, October 7–9 in Gothenburg, Sweden.
A specialized symposium focused on bone grafting solutions, reconstructive procedures.
Bringing together our global distribution partners to share strategies and strengthen collaboration.
Explore the latest advancements in regenerative medicine, tissue engineering, and biologic solutions.